Characteristic for methicillin-resistant (Mcr) staphylococci is the heterogeneous expression of the intrinsic methicillin resistance. The majority of the cells express resistance to low concentrations of methicillin, and a minority of the cells express resistance to much higher concentrations. We show here (i) progeny. Transductants derived from the formerly highly resistant cured strain became resistant to high concentrations of methicillin, whereas transductants derived from the original parent strain were resistant to lower concentrations of methicillin and showed the typical heterogeneous resistance. We deduced therefrom that the high-level resistance expressed by the minority of the population of Mcr S. aureus was due to a chromosomal mutation(s) (chr*) involving neither mecA nor the additional 30 kb of mec-associated DNA. Moreover, we could show that this postulated mutation chr* was not linked to the femAB operon, which is known to affect methicillin resistance levels.
Staphylococcus aureus strain heteroresistant and (ii) that this Mcr strain segregated highly resistant subclones which retained the high-resistance phenotype under nonselective growth conditions. The Mcr strain with only mecA on plasmid pBBB79 thus behaved identically to a Mcr strain carrying the complete mec determinant integrated at its proper chromosomal site. (iii) Curing a such highly resistant subclone from plasmid pBBB79 yielded an Mcs strain that was as susceptible as the original Mcs parent strain. (iv) Comparisons were made between the original parent and the cured Mcs strain by backcrossing pBBB79 into them and looking at their progeny. Transductants derived from the formerly highly resistant cured strain became resistant to high concentrations of methicillin, whereas transductants derived from the original parent strain were resistant to lower concentrations of methicillin and showed the typical heterogeneous resistance. We deduced therefrom that the high-level resistance expressed by the minority of the population of Mcr S. aureus was due to a chromosomal mutation(s) (chr*) involving neither mecA nor the additional 30 kb of mec-associated DNA. Moreover, we could show that this postulated mutation chr* was not linked to the femAB operon, which is known to affect methicillin resistance levels.
Clinical isolates of methicillin-resistant (Mcr) Staphylococcus aureus contain the methicillin resistance determinant mec, which confers an intrinsic resistance to all P-lactam antibiotics.
The mec determinant is located on additional DNA of unknown origin and nature and integrates into a specific site in the chromosome of S. aureus (14) . The mec determinant codes for mecA, the structural gene for low-affinity penicillin-binding protein (PBP2' or PBP2a). This PBP2' adds to the existing PBPs of the cell and is the biochemical correlate of methicillin resistance (13, 18, 28) . Some strains contain mecRI-mecI, which code for elements regulating mecA transcription (23, 26, 27) . Only a small part of the remaining 30 kb of DNA associated with mecA (3) has been characterized. It (20) . However, loss of these duplications was not correlated with loss of high resistance. Amplification seems, therefore, not to be involved in high-level resistance. Alterations in the inducibility of PBP2' were proposed to be responsible for higher resistance in the highly resistant subpopulation (8) . Mcr strains with a functioning negative regulatory region mecRl-mecl upstream of mecA (27) express very low resistance when uninduced (23) . Mutations or deletions in mecI relieve this repression (26) , and resistance is increased. An analogous, though not as stringent, control of mecA occurs through blaRl-blaI (11, 23) , the regulatory elements of staphylococcal 1-lactamase. However, the amount of PBP2' produced apparently does not correlate with resistance levels. Mcr strains, i.e., strains devoid of mecRi-mecI and blaRl-blaI and therefore capable of high constitutive synthesis of PBP2', show heterogeneous resistance and segregate into highly resistant subclones. It is unknown which genetic and physiological alterations have occurred in these subclones.
Besides PBP2', genes termed fem (4, 5) or aux (21) factors are needed for the expression of the resistance. They are part of the S. aureus genome and are involved in peptidoglycan metabolism (9, 16) . Inactivation of the femAB operon decreases resistance to methicillin without affecting PBP2' production (5, 12) and might, therefore, be involved in one way or another in high resistance.
In the present study we could show that the mutation(s) leading to high resistance is located on the chromosome but that it must differ from femAB. Since the cured strains apparently did not differ from each other in terms of behavior towards methicillin, we addressed the question of whether the information for high-level resistance was still present. If yes, it might be located either on the plasmid of the highly resistant mutant or on the genome of the cured strain. Phage 80oa-mediated transductions were therefore performed with either susceptible parent strain BB255 or susceptible strain BB868, the cured descendant from high-level resistant subclone BB865, as a recipient. The donor of the mecA-containing plasmid pBBB79 was either heterogeneously Mcr strain BB749 or highly Mcr strain BB865. Transductants were selected for growth on chloramphenicol and replica plated on 5 or 100 mg methicillin per liter, to discern between heterogeneous and high methicillin resistance. Independently of the origin of the plasmid, it was the genetic background of the recipient's genome which determined the resistance levels of the transductants (Fig. 1C) . When strain BB255 was used as a receptor, heterogeneously methicillin-resistant transductants, namely, strains BB866 and BB867, were obtained, independently from the origin of pBBB79. When strain BB868 was the receptor, all transductants, represented here by BB871 and BB872, respectively, were highly resistant.
Methicillin resistance can be acquired in vitro by stepwise selection of a susceptible strain for growth on increasing concentrations of methicillin. This yields homogeneously Mcr mutants, as shown earlier (7) and in Fig. 1D for the fourth-step Mcr mutant BB582. We wondered whether introduction of mecA on pBBB79 into mutant BB582 would increase the resistance and would lead to heterogeneity. Resistance was increased in the resulting transductant BB936 (Fig. 1D) left or right of the femAB region (Fig. 2) , known to be cotransducible with fem"AB (6). High-level resistant mutants BB892 and BB894, respectively, were isolated therefrom. BB892 and BB894 acted as donors, and heterogeneous Mcr strain BB270 acted as a recipient in phage 80a-mediated transductions of TnS5l. All erythromycin-resistant transductants obtained were replica plated on 100 or 5 mg of methicillin per liter to see whether high-level resistance was linked to any of these TnSSl inserts close tofemAB. However, from over 100 transductants analyzed all were still heterogeneously Mcr; none had acquired high-level resistance.
DISCUSSION
The heterogeneous expression of methicillin resistance is typical for Mcr S. aureus. The level of resistance is strain specific and varies from borderline resistance to high basal resistance depending upon the genetic background of the strains (29) . Independently from these variations, there appears within each culture a highly resistant subpopulation with high-level resistance. High-level resistant subclones are generally stable and retain their high-level resistance trait upon repeated passages in drug-free broth. We showed that an Mcr strain with mecA on plasmid pBBB79 produced a highly resistant minority as do clinical Mcr isolates containing the mec determinant in the chromosome. Since these high-level resistant mutants arose in the presence of mecA alone, in the absence of the additional 30 kb of mec-associated DNA, we could rule out that the additional DNA plays any role in high-level resistance. Resistance to high concentrations of methicillin was shown here to be the consequence of alterations encoded by the chromosome. It was the genetic background of the recipient strain which determined the outcome of the resistance level in the transductants which had acquired pBBB79. The previous passages of the pBBB79 plasmid, whether in highly or heterogeneously Mcr strains, did not affect plasmid-encoded genes. We termed the unknown chromosomal mutation(s) leading to high resistance in the presence of PBP2' chr*. The mutation rate of 10'6 to high resistance in our strain points presumably to one single mutational event.
In susceptible strains selected for growth on increasing concentrations of methicillin, high resistance is acquired in small increments, resulting in changes in affinity to penicillin and the amount of the existing PBPs and in further, not yet characterized alterations (7) . Since pBBB79 in strain BB936 increased the resistance of the in vitro Mcr mutant but apparently did not produce heterogeneity, it might be postulated that the chr* mutation had already occurred during step selection.
The chr* mutation is not cotransducible with the two silent TnS51 insertions surrounding femAB. Its chromosomal location is still not known.
The highly resistant subclones are not genetically stable in all strains (24) , as shown here. In some strains subclones picked at high concentration revert more readily. Recently (10) , resistant subclones selected at 25 mg/liter which reverted readily to their original resistance pattern were described. They were uncharacterized strains, and their behavior is reminiscent of an induction phenomenon. Induction of resistance by ,-lactams, especially in strains with the negative regulatory element mecRl-mecI can, once induced, be mistaken for the genetically determined high-level resistance discussed above. Expression of methicillin resistance is very complex. The nature of chr* is intriguing; the phenotype of chr* is not apparent in the susceptible strain BB868 and appears only after introduction of PBP2'. The mapping and isolation of the putative chromosomal high-resistance gene chr* will be a step forward in methicillin resistance genetics and will help to elucidate the molecular mechanism of high methicillin resistance.
